We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALEC market cap is 186.06M. The company's latest EPS is USD -1.3314 and P/E is -1.40.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 9.11M | 15.19M | 15.89M | 15.08M | 15.34M |
Operating Income | -50.58M | -47.45M | -43.71M | -45.61M | -48.43M |
Net Income | -44.48M | -41.43M | -36.08M | -38.68M | -42.22M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 21.22M | 21.1M | 207.09M | 133.62M | 97.06M |
Operating Income | -114.4M | -195.17M | -37.36M | -137.83M | -151.74M |
Net Income | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 672.4M | 621.83M | 635.49M | 570.73M | 516.02M |
Total Liabilities | 509.84M | 487.67M | 456.59M | 420.16M | 397.09M |
Total Equity | 162.56M | 134.16M | 178.91M | 150.57M | 118.93M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 421.91M | 488.25M | 814.66M | 787.65M | 621.83M |
Total Liabilities | 227.17M | 220.72M | 513.93M | 573.21M | 487.67M |
Total Equity | 194.74M | 267.53M | 300.72M | 214.44M | 134.16M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -138.09M | -184.16M | -61.35M | -124.14M | -174.88M |
Investing | 83.85M | 101.92M | -11.77M | 25.38M | 65.73M |
Financing | 1.96M | 2.55M | 71.11M | 71.75M | 71.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -99.31M | -166.73M | 298.55M | -20.33M | -184.16M |
Investing | -48.87M | -105.05M | -49.66M | -159.01M | 101.92M |
Financing | 172.35M | 232.11M | 30.3M | 4.51M | 2.55M |
Market Cap | 186.06M |
Price to Earnings Ratio | -1.40 |
Price to Sales Ratio | 1.88 |
Price to Cash Ratio | 2.44 |
Price to Book Ratio | 1.36 |
Dividend Yield | - |
Shares Outstanding | 97.93M |
Average Volume (1 week) | 1.29M |
Average Volume (1 Month) | 2.12M |
52 Week Change | -77.27% |
52 Week High | 8.90 |
52 Week Low | 1.735 |
Spread (Intraday) | 0.17 (8.76%) |
Company Name | Alector Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.alector.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions